BRIEF—Indivior to launch its own generic Suboxone

UK-based Indivior says it will launch an authorized generic of its Suboxone Film (buprenorphine/naloxone) product, once generic competitors enter the market.

The firm says the launch is expected to capture some share of the generic segment and generate a small amount of net revenue in the range of tens of millions of dollars.

The firm has been engaged in litigation to delay the launch of generic competitors, which have been approved for marketing in the USA since June 2018.